CAR- T and also cellular gene therapies are also costly

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production as well as technology transfer may provide cell gene therapies at a cost effective price to patients all over the world.